1. Comparative pharmacokinetics and bioavailability of marbofloxacin in geese (Anser Anser domesticus) after two sites of intramuscular administrations;Abo-EL-Sooud;J. Vet. Pharmacol. Therap.,2020
2. Anonymous, 2012. Guideline on Bioanalytical Method Validation. EMEA/CHMP/EWP/192217/2009. EMA Committee for Medicinal Products for Human Use (CHMP) Rev. 1 Corr. 2** http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf. Accessed 10 Sept 2020, 44 (July 2011). 2012; 1–23: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf%5Cnhttp://www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500109686&mid=WC0b01ac058009a3dc.
3. Guideline on Determination of Withdrawal Periods for Edible Tissues;Anonymous,2018
4. Fluoroquinolones in animal health;Brown;J. Vet. Pharmacol. Ther.,1996
5. Comparison of the efficacies of three fluoroquinolone antimicrobial agents, given as continuous or pulsed-water medication, against Escherichia coli infection in chickens;Charleston;Antimicrob. Agents Chemother.,1998